Vyant Bio to Present at The Benchmark Company Discovery One-on-One Investor Conference

NEXT STORY
Life Science Reagents Market to Hit USD 78 Billion by 2030
PREV STORY
Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

BOSTON, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Terveystalo Plc: Changes in the Composition of Shareholders’ Nomination Board

Terveystalo Plc Stock Exchange release 8 June 2018 at 14:35 p.m. EEST The Helsinki ...

author_avatar
NASDAQ Market News

Galena Biopharma to Provide Corporate and Clinical Update and 2017 Outlook During Presentation at Biotech Showcase 2017

SAN RAMON, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

author_avatar
NASDAQ Market News